MICHELLE A FANALE to Everolimus
This is a "connection" page, showing publications MICHELLE A FANALE has written about Everolimus.
Connection Strength
0.630
-
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma. Clin Cancer Res. 2020 11 01; 26(21):5579-5587.
Score: 0.607
-
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma. Clin Cancer Res. 2013 Dec 15; 19(24):6882-90.
Score: 0.023